Lambden Jason, Zhang Baohui, Friedlander Robert, Prigerson Holly G
Center for Research on End-of-Life Care , Weill Cornell Medicine, New York, New York.
J Palliat Med. 2016 Dec;19(12):1296-1303. doi: 10.1089/jpm.2016.0121. Epub 2016 Aug 30.
Oncologists are often reluctant to discuss life-expectancy estimates with their patients because of concerns about their inaccuracy and limited evidence regarding benefits.
Determine oncologist accuracy in predicting their advanced cancer patients' life expectancy and correlates associated with accuracy.
Multicenter prospective, longitudinal study of patients with advanced cancer, assessed once at baseline and followed to death. At baseline, patients were asked whether their oncologist had provided them with a life-expectancy estimate.
SETTING/SUBJECTS: Eighty-five patients with advanced cancer recruited from outpatient cancer clinics.
Patients' baseline sociodemographic and time to death, and clinical characteristics were examined to determine their associations with the accuracy of the oncologists' life-expectancy estimates as recalled by their patients.
Seventy-four percent (63/85) of patients recalled that physician life-expectancy estimates were accurate to within a year; estimates were most accurate when patients had 9-12 months to live. Factors significantly (p < 0.05) positively associated with oncologists' greater accuracy to within a year were the patient's age, recruitment from a community-based oncology clinic, poor performance status, and quality-of-life at baseline. Oncologists' prognoses that were accurate to within a year were associated with greater likelihood of patients, at baseline, acknowledging that they were terminally ill (OR = 12.20, 95% CI = 2.24-66.59), engaging in an end-of-life discussion (OR = 4.22, 95% CI = 1.45-12.29), completing a do-not-resuscitate (DNR) order (OR = 2.94, 95% CI = 1.03-8.41), a lower likelihood of using palliative chemotherapy (OR = 0.30, 95% CI = 0.11-0.85), and clinical trial enrollment (OR = 0.09, 95% CI = 0.02-0.50).
Oncologists are able to estimate their patients' life expectancy to within a year. Accuracy to within a year is associated with higher rates of DNR order completion, advance care planning, and lower likelihood of chemotherapy use near death.
肿瘤学家通常不愿与患者讨论预期寿命估计,因为担心其不准确且关于益处的证据有限。
确定肿瘤学家预测晚期癌症患者预期寿命的准确性以及与准确性相关的因素。
对晚期癌症患者进行多中心前瞻性纵向研究,在基线时评估一次,并随访至死亡。在基线时,询问患者其肿瘤学家是否为他们提供了预期寿命估计。
设置/对象:从门诊癌症诊所招募的85例晚期癌症患者。
检查患者的基线社会人口统计学、死亡时间和临床特征,以确定它们与患者回忆的肿瘤学家预期寿命估计准确性之间的关联。
74%(63/85)的患者回忆称医生的预期寿命估计在一年内准确;当患者还有9至12个月的生命时,估计最为准确。与肿瘤学家在一年内更高准确性显著(p < 0.05)正相关的因素包括患者年龄、从社区肿瘤诊所招募、较差的体能状态以及基线时的生活质量。肿瘤学家在一年内准确的预后与患者在基线时承认自己处于绝症状态的可能性更高(OR = 12.20,95% CI = 2.24 - 66.59)、进行临终讨论(OR = 4.22,95% CI = 1.45 - 12.29)、完成不进行心肺复苏(DNR)医嘱(OR = 2.94,95% CI = 1.03 - 8.41)、使用姑息性化疗的可能性较低(OR = 0.30,95% CI = 0.11 - 0.85)以及参加临床试验(OR = 0.09,95% CI = 0.02 - 0.50)相关。
肿瘤学家能够将患者的预期寿命估计在一年内。一年内的准确性与更高的DNR医嘱完成率、预先护理计划以及临终时使用化疗的可能性较低相关。